Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,013 public trials 2,032 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Pasireotide in Prevention of GI Toxicity

NCT02215070

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +22 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

A Phase 1/2a Study of Human Anti-CD 38 Antibody MOR03087 (MOR202) in Relapsed/Refractory Multiple Myeloma

NCT01421186

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • AKH (Allgemeines Krankenhaus der Stadt Wien), Abteilung für Klinische Onkologie, Universitätsklinik für Innere Medizin I Vienna, Austria
  • Charité - Universitätsmedizin Berlin, CBF: Campus Benjamin Franklin, CC 14: Tumormedizin, Medizinische Klinik mit Schwerpunkt Hämatologie, Onkologie Berlin, Germany
  • Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus Dresden, Germany
  • Medizinische Klinik 5 - Hämatologie und Internist. Onkologie, Universitätsklinikum Erlangen Erlangen, Germany
View Trial Details
Completed

Study of Pralatrexate to Treat Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

NCT00998946

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • Kootenai Cancer Center Post Falls, Idaho, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Owsley Brown Frazier Cancer Center Louisville, Kentucky, United States
View Trial Details

Related conditions